296 related articles for article (PubMed ID: 12351423)
21. AICAR administration affects glucose metabolism by upregulating the novel glucose transporter, GLUT8, in equine skeletal muscle.
de Laat MA; Robinson MA; Gruntmeir KJ; Liu Y; Soma LR; Lacombe VA
Vet J; 2015 Sep; 205(3):381-6. PubMed ID: 26116041
[TBL] [Abstract][Full Text] [Related]
22. Activation of insulin signaling and energy sensing network by AICAR, an AMPK activator in insulin resistant rat tissues.
Radika MK; Anuradha CV
J Basic Clin Physiol Pharmacol; 2015 Nov; 26(6):563-74. PubMed ID: 26124049
[TBL] [Abstract][Full Text] [Related]
23. Chronic treatment with the AMP-kinase activator AICAR increases glycogen storage and fatty acid oxidation in skeletal muscles but does not reduce hyperglucagonemia and hyperglycemia in insulin deficient rats.
Vitzel KF; Bikopoulos G; Hung S; Pistor KE; Patterson JD; Curi R; Ceddia RB
PLoS One; 2013; 8(4):e62190. PubMed ID: 23620811
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of insulin-stimulated glycogen synthesis by 5-aminoimidasole-4-carboxamide-1-beta-d-ribofuranoside-induced adenosine 5'-monophosphate-activated protein kinase activation: interactions with Akt, glycogen synthase kinase 3-3alpha/beta, and glycogen synthase in isolated rat soleus muscle.
Fediuc S; Gaidhu MP; Ceddia RB
Endocrinology; 2006 Nov; 147(11):5170-7. PubMed ID: 16873531
[TBL] [Abstract][Full Text] [Related]
25. Short-term AMP-regulated protein kinase activation enhances insulin-sensitive fatty acid uptake and increases the effects of insulin on fatty acid oxidation in L6 muscle cells.
Kelly KR; Abbott MJ; Turcotte LP
Exp Biol Med (Maywood); 2010 Apr; 235(4):514-21. PubMed ID: 20407084
[TBL] [Abstract][Full Text] [Related]
26. 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.
Hasenour CM; Ridley DE; Hughey CC; James FD; Donahue EP; Shearer J; Viollet B; Foretz M; Wasserman DH
J Biol Chem; 2014 Feb; 289(9):5950-9. PubMed ID: 24403081
[TBL] [Abstract][Full Text] [Related]
27. Intracerebroventricular infusion of glucose, insulin, and the adenosine monophosphate-activated kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, controls muscle glycogen synthesis.
Perrin C; Knauf C; Burcelin R
Endocrinology; 2004 Sep; 145(9):4025-33. PubMed ID: 15192044
[TBL] [Abstract][Full Text] [Related]
28. 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes.
Salt IP; Connell JM; Gould GW
Diabetes; 2000 Oct; 49(10):1649-56. PubMed ID: 11016448
[TBL] [Abstract][Full Text] [Related]
29. Blunting of AICAR-induced human skeletal muscle glucose uptake in type 2 diabetes is dependent on age rather than diabetic status.
Babraj JA; Mustard K; Sutherland C; Towler MC; Chen S; Smith K; Green K; Leese G; Hardie DG; Rennie MJ; Cuthbertson DJ
Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1042-8. PubMed ID: 19190259
[TBL] [Abstract][Full Text] [Related]
30. Leptin administration improves skeletal muscle insulin responsiveness in diet-induced insulin-resistant rats.
Yaspelkis BB; Davis JR; Saberi M; Smith TL; Jazayeri R; Singh M; Fernandez V; Trevino B; Chinookoswong N; Wang J; Shi ZQ; Levin N
Am J Physiol Endocrinol Metab; 2001 Jan; 280(1):E130-42. PubMed ID: 11120667
[TBL] [Abstract][Full Text] [Related]
31. Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes.
Sakoda H; Ogihara T; Anai M; Fujishiro M; Ono H; Onishi Y; Katagiri H; Abe M; Fukushima Y; Shojima N; Inukai K; Kikuchi M; Oka Y; Asano T
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1239-44. PubMed ID: 12006353
[TBL] [Abstract][Full Text] [Related]
32. Chronic AMP-activated protein kinase activation and a high-fat diet have an additive effect on mitochondria in rat skeletal muscle.
Fillmore N; Jacobs DL; Mills DB; Winder WW; Hancock CR
J Appl Physiol (1985); 2010 Aug; 109(2):511-20. PubMed ID: 20522731
[TBL] [Abstract][Full Text] [Related]
33. Prior serum- and AICAR-induced AMPK activation in primary human myocytes does not lead to subsequent increase in insulin-stimulated glucose uptake.
Al-Khalili L; Krook A; Zierath JR; Cartee GD
Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E553-7. PubMed ID: 15149951
[TBL] [Abstract][Full Text] [Related]
34. Effect of AMPK activation on muscle glucose metabolism in conscious rats.
Bergeron R; Russell RR; Young LH; Ren JM; Marcucci M; Lee A; Shulman GI
Am J Physiol; 1999 May; 276(5):E938-44. PubMed ID: 10329989
[TBL] [Abstract][Full Text] [Related]
35. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.
Oakes ND; Kennedy CJ; Jenkins AB; Laybutt DR; Chisholm DJ; Kraegen EW
Diabetes; 1994 Oct; 43(10):1203-10. PubMed ID: 7926289
[TBL] [Abstract][Full Text] [Related]
36. AMPK activation is not critical in the regulation of muscle FA uptake and oxidation during low-intensity muscle contraction.
Raney MA; Yee AJ; Todd MK; Turcotte LP
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E592-8. PubMed ID: 15547141
[TBL] [Abstract][Full Text] [Related]
37. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.
Sakamoto K; Göransson O; Hardie DG; Alessi DR
Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E310-7. PubMed ID: 15068958
[TBL] [Abstract][Full Text] [Related]
38. Effect of the AMP-kinase modulators AICAR, metformin and compound C on insulin secretion of INS-1E rat insulinoma cells under standard cell culture conditions.
Langelueddecke C; Jakab M; Ketterl N; Lehner L; Hufnagl C; Schmidt S; Geibel JP; Fuerst J; Ritter M
Cell Physiol Biochem; 2012; 29(1-2):75-86. PubMed ID: 22415077
[TBL] [Abstract][Full Text] [Related]
39. Chronic activation of central AMPK attenuates glucose-stimulated insulin secretion and exacerbates hepatic insulin resistance in diabetic rats.
Park S; Kim DS; Kang S; Shin BK
Brain Res Bull; 2014 Sep; 108():18-26. PubMed ID: 25149877
[TBL] [Abstract][Full Text] [Related]
40. Muscle contractions, AICAR, and insulin cause phosphorylation of an AMPK-related kinase.
Fisher JS; Ju JS; Oppelt PJ; Smith JL; Suzuki A; Esumi H
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E986-92. PubMed ID: 16030062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
